Whistleblower Act
January 21, 2014
RehabCare Group Inc. has agreed to pay $30 million to resolve allegations that they violated the False Claims Act by engaging in a kickback scheme related to the referral of nursing home businesses, the Justice Department announced last week.
RehabCare allegedly arranged to obtain Rehab Systems of Missouri’s contracts to provide therapy to patients residing...
January 17, 2014
BioScrip has agreed to pay $15 million to resolve allegations under the False Claims Act that they received kickbacks from Novartis in exchange for recommending refills to patients, the Department of Justice announced earlier this week.
Novartis allegedly provided kickbacks to BioScrip, in the form of patient referrals and in the guise of rebates, in exchange for BioScrip...
BioScrip, Exjade, False Claims Act, Medicaid, Medicaid Fraud, Medicare Fraud, Novartis, qui tam lawsuit, Whistleblower Act, whistleblower attorneys
January 13, 2014
St. Mary Medical Center has agreed to pay over $2.3 million to resolve allegations under the False Claims Act that it failed to administer certain contracts which led to overbilling from physicians, the Department of Justice announced last week. St. Mary voluntarily disclosed the allegations.
According to the self-disclosure and subsequent investigation, St. Mary admitted that...
January 10, 2014
Michael R. Barr, former chief executive officer for HealthEssentials Solutions Inc., has agreed to pay $1 million to resolve allegations that he violated the False Claims Act by causing HealthEssentials to submit false claims to Medicare, the Justice Department announced today.
The government alleged that HealthEssentials billed for services that were inflated or not medically...
Barr, False Claims Act, HealthEssentials, Medicare Fraud, qui tam lawsuit, Whistleblower Act, whistleblower attorneys
January 9, 2014
CareFusion Corp. has agreed to pay $40.1 million to settle allegations that it violated the False Claims Act by paying kickbacks and promoting its products for uses that were not approved by the Food and Drug Administration (FDA), the Justice Department announced today.
CareFusion, a medical technology company which develops, manufactures, and sells pharmaceutical...
January 8, 2014
Dr. Ravi Sharma has agreed to pay $400,000 to resolve allegations that he and his clinics violated the False Claims Act by billing Medicare for vein injections and physician office visits performed by unqualified personnel, the Justice Department announced yesterday.
Sharma, who owned and operated the clinic Premier Vein Centers, allegedly messaged his office manager...
False Claims Act, Fraud, Medicare Fraud, qui tam lawsuit, Sharma, Whistleblower Act, whistleblower attorneys
January 3, 2014
The United States has intervened in a False Claims Act case against Florida-based Health Management Associates, Inc. (HMA), after uncovering allegations of unlawful kickbacks and improper billing claims to federal healthcare entities such as Medicare and Medicaid, the Atlanta Business Chronicle announced last month.
HMA allegedly encouraged physicians to inappropriately admit...
December 31, 2013
St. James Healthcare (St. James) and its parent company, Sisters of Charity of Leavenworth Health System (Sisters of Charity), have agreed to pay $3.85 million to resolve allegations that they violated the False Claims Act, the Anti-Kickback Statute and the Stark Law, the Department of Justice announced today.
Allegedly, St. James knowingly provided financial benefits to...
December 30, 2013
Taylor Bean & Whitaker Mortgage may pay the United States more than $320 million to resolve allegations that they violated the False Claims Act submitting false mortgage claims, Bloomberg Businessweek announced earlier this month.
The settlement would resolve allegations that Taylor Bean knowingly submitted fraudulent mortgages to the Federal Housing Administration (FHA)...
False Claims Act, Fraud Against Government, mortgage fraud, qui tam lawsuit, Taylor Bean, Whistleblower Act, whistleblower attorneys
December 23, 2013
Genzyme Corp. (Genzyme) has agreed to pay $22.28 million to resolve allegations, under the False Claims Act, that they knowingly marketed and caused false claims to be submitted to federal and state health care programs for use of a “slurry” version of its Seprafilm adhesion barrier, the Justice Department announced today.
Seprafilm is a thin film...
False Claims Act, Genzyme, Genzyme Corp., qui tam lawsuit, slurry, Whistleblower Act, whistleblower attorneys
Search Our Site
Subscribe to Our Blogs
Sign up for our newsletter to keep up-to-date with the latest important news from The Chanler Group
Contact Our Team
Use our online contact form, or visit our offices page for more details on how to reach us.
Want to apply for a grant? Check out our Grant Seeker FAQ.
If you want to contact a whistleblower attorney, please take a look at our Whistleblower Questionnaire.